Upstream Process Development: A Standardized Modular Work Platform for Expediting Delivery of Biologics
As a CDMO, the development of an efficient, robust, and reproducible upstream process is key to the successful market supply of a biologic drug. Cell culture optimization involves the development of a customized basal medium along with process-specific feed, all combined with operating parameters tailored for each CHO cell clone. For comprehensive process development, United BioPharma (UBP) provides a standardized modular work platform that allows for a flexible upstream process development that meets anticipated goals in safety, product quality, quantity, scalability, and process robustness. This platform aims to improve cell growth, and productivity, customize product quality and ensure scalability by systematically optimizing process and media factors.